Login / Signup

Prevalence of Cardioprotective Medication Use in Coronary Heart Disease Patients in South America: Systematic review and Meta-Analysis.

Anna Marzà-FlorensaElizabeth DrotosPablo Elías GulayinDiederick E GrobbeeVilma Edith IrazolaKerstin Klipstein-GrobuschIlonca Vaartjes
Published in: Global heart (2022)
Cardioprotective medication use has increased, but could be further improved particularly in community settings.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • chronic kidney disease
  • newly diagnosed
  • healthcare
  • risk factors
  • prognostic factors